183 filings
Page 2 of 10
425
l5lr4 m40
30 Jan 24
Business combination disclosure
9:05am
8-K
9an8d newm0t
30 Jan 24
AVROBIO and Tectonic Therapeutic Announce Merger
8:39am
RW
p6fiyoa81za1f2ogcp
3 Nov 23
Registration withdrawal request
4:15pm
8-K
sx05ph2c756vqp6wyist
12 Jul 23
AVROBIO to Explore Strategic Alternatives
7:13am
8-K/A
th3 qr0ab13ptd29zmx
14 Jun 23
Cost Associated with Exit or Disposal Activities
5:19pm
8-K
rifcyxe8l inv
13 Jun 23
Other Events
4:41pm
8-K
giw00g
12 Jun 23
Termination of a Material Definitive Agreement
7:19am
8-K
dny1gatwvwld5te
9 Jun 23
Departure of Directors or Certain Officers
4:11pm
8-K
syku3 b2rd3unz0
22 May 23
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million
7:04am
8-K
dkckg8 d9c
18 May 23
AVROBIO Announces Positive Data from Phase 1/2 Clinical Trial of
7:11am
8-K
zx6bm4je
11 May 23
AVROBIO Reports First Quarter 2023 Financial Results and Provides Business Update
7:20am
ARS
cehh wf3r
5 May 23
Annual report to shareholders
4:00pm
8-K
qng7egxdpmoucrpi77a
1 May 23
AVROBIO Announces Leadership Transition
7:40am
S-8
ve3d0a
23 Mar 23
Registration of securities for employees
4:58pm
8-K
cj16gd5uz6
23 Mar 23
AVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
7:11am